Transcatheter Aortic Valve Implantation (TAVI) Market Research, 2030 Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during the ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a ...

Four complex heart surgeries were done without a single chest cut using TPVR Read ahead to know how this minimally invasive ...

Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...

Israeli clinical stage medical company Restore Medical, which is developing transcatheter therapies for heart failure, has ...

Transcatheter aortic valve implantation (TAVI) is a proven treatment for life-threatening aortic valve disease, predominantly severe aortic stenosis. However, even among developed nations, access to ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

The country represented 10% of the Asia-Pacific market in 2024. India’s transcatheter mitral valve repair (TMVR) market is ...